EquityZen Growth Technology Fund LLC - Series 74
Raised
$120K
Investors
6
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 74 is a Delaware-based pooled investment fund filed February 2, 2017, that raised $120K from 6 investors under Rule 506(b) and Section 3(c)(1) exemptions. The entity is part of the EquityZen platform, a pre-IPO investment manager with 1,891 related EDGAR entities offering access to private company equity through special-purpose vehicles.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption structure typical of private equity pooled vehicles, limiting the fund to 99 beneficial owners. The $20K average investor commitment is consistent with retail-accessible SPV structures designed to aggregate smaller investors for access to individual private company positions, common in the EquityZen platform's Series-based fund architecture.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Inc.
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II LLC
Director · Salt Lake City, X1
Mateo Johnson
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
